295 related articles for article (PubMed ID: 28477388)
61. The immunophenotype of osteoclasts and macrophage polykaryons.
Maggiani F; Forsyth R; Hogendoorn PC; Krenacs T; Athanasou NA
J Clin Pathol; 2011 Aug; 64(8):701-5. PubMed ID: 21561891
[TBL] [Abstract][Full Text] [Related]
62. Apoptosis in giant cell tumors of bone.
Kakizoe M
Kurume Med J; 2000; 47(2):125-34. PubMed ID: 10948650
[TBL] [Abstract][Full Text] [Related]
63. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.
Yoshida KI; Nakano Y; Honda-Kitahara M; Wakai S; Motoi T; Ogura K; Sano N; Shibata T; Okuma T; Iwata S; Kawai A; Ichimura K; Yoshida A
Mod Pathol; 2019 Dec; 32(12):1751-1761. PubMed ID: 31285528
[TBL] [Abstract][Full Text] [Related]
64. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
[TBL] [Abstract][Full Text] [Related]
65. Epigenetic lockdown of CDKN1A (p21) and CDKN2A (p16) characterises the neoplastic spindle cell component of giant cell tumours of bone.
Giesche J; Mellert K; Geißler S; Arndt S; Seeling C; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TF
J Pathol; 2022 Aug; 257(5):687-696. PubMed ID: 35522566
[TBL] [Abstract][Full Text] [Related]
66. Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.
Guenther R; Krenn V; Morawietz L; Dankof A; Melcher I; Schaser KD; Kasper HU; Kuban RJ; Ungethüm U; Sers C
Pathol Res Pract; 2005; 201(10):649-63. PubMed ID: 16325507
[TBL] [Abstract][Full Text] [Related]
67. Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors.
Chen S; Li C; Wu B; Zhang C; Liu C; Lin X; Wu X; Sun L; Liu C; Chen B; Zhong Z; Xu L; Li E
Int J Oncol; 2014 Sep; 45(3):1133-42. PubMed ID: 24969034
[TBL] [Abstract][Full Text] [Related]
68. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
69. Giant cell tumor of soft tissue arising in breast.
May SA; Deavers MT; Resetkova E; Johnson D; Albarracin CT
Ann Diagn Pathol; 2007 Oct; 11(5):345-9. PubMed ID: 17870021
[TBL] [Abstract][Full Text] [Related]
70. A clinicopathological study of giant cell tumor of small bones.
Yanagisawa M; Okada K; Tajino T; Torigoe T; Kawai A; Nishida J
Ups J Med Sci; 2011 Nov; 116(4):265-8. PubMed ID: 21919814
[TBL] [Abstract][Full Text] [Related]
71. Recurrent primary mediastinal giant cell tumor of soft tissue with radiological findings: a rare case report and literature review.
Hu Q; Peng J; Xia L
World J Surg Oncol; 2017 Jul; 15(1):137. PubMed ID: 28747182
[TBL] [Abstract][Full Text] [Related]
72. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
73. [Clinicopathologic differential diagnosis of giant cell-rich osteosarcoma and giant cell tumor of bone].
Huang J; Jiang Z; Zhang H
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):379-82. PubMed ID: 25208987
[TBL] [Abstract][Full Text] [Related]
74. Analysis of chromosomal imbalances in an elderly woman with a giant cell tumour.
García JL; Robledo C; Lumbreras E; Flores T; Ramos L; Hernández JM
Virchows Arch; 2006 Jan; 448(1):95-9. PubMed ID: 16220295
[TBL] [Abstract][Full Text] [Related]
75. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
[TBL] [Abstract][Full Text] [Related]
76. Giant cell tumour of a temporomandibular joint presenting as a parotid mass: case report and analysis of the 19 cases in the literature.
Huang YC; Chen JW; Chen YL; Lou PJ
J Craniomaxillofac Surg; 2014 Dec; 42(8):1778-82. PubMed ID: 25008031
[TBL] [Abstract][Full Text] [Related]
77. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
78. Chondroblastoma Expresses RANKL by RNA In Situ Hybridization and May Respond to Denosumab Therapy.
Suster DI; Kurzawa P; Neyaz A; Jarzembowski JA; Lozano-Calderon S; Raskin K; Schwab J; Choy E; Chebib I; Deshpande V
Am J Surg Pathol; 2020 Dec; 44(12):1581-1590. PubMed ID: 32826531
[TBL] [Abstract][Full Text] [Related]
79. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
[TBL] [Abstract][Full Text] [Related]
80. Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.
Alberghini M; Kliskey K; Krenacs T; Picci P; Kindblom L; Forsyth R; Athanasou NA
Virchows Arch; 2010 Jan; 456(1):97-103. PubMed ID: 20012988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
